CD4 and cancer: Zhang et al. profiled and integrated scRNA-seq data of 397,810 T cells from 316 patients of 21 cancer types, and depicted the pan-cancer landscape of T cells (including 17 CD8+ and 24 CD4+ subclusters) in the TME6.